NIAID


Also found in: Acronyms.

National Institute of Allergy and Infectious Diseases

 (NIAID)
an institute of the national institutes of health; its research strives to understand, treat, and ultimately prevent infectious, immunologic, and allergic disorders affecting human beings.

NIAID

National Institute of Allergy and Infectious Diseases.

National Institute of Allergy and Infectious Diseases (NIAID)

an institute of the National Institutes of Health whose mission is to understand, treat, and ultimately prevent infectious, immunological, and allergic disorders affecting human beings.

NIAID

National Institute of Allergy and Infectious Diseases.
References in periodicals archive ?
The test vaccine contains no thimerosal or adjuvant, according to NIAID.
NIAID supports a number of international research programs on infectious diseases, including HIV/AIDS.
Many expand or build upon existing NIAID bioterrorism or infectious disease research programs.
In another research study, scientists supported by NIAID found that an investigational flu vaccine sprayed as a fine mist into children's nostrils is highly effective in preventing both the flu and otitis media, a common flu-related ear infection.
As the regulatory sponsor, NIAID ensures the trial follows the study protocol and informs the FDA of any significant adverse events or risks.
Following the additional NIAID award, the company's BCX4430 development contract has been increased in value to USD26.
In Fall 2003, the company was awarded a contract by the NIAID in the United States to develop and produce an inactivated coronavirus vaccine against Severe Acute Respiratory Syndrome (SARS) for use by the NIH in phase I/II clinical trials.
The research supported by this RFA will contribute to meeting the goals for host defense described in the NIAID Strategic Plan for Biodefense, which is located at: http://www2.
The AP published selected internal NIAID emails, memos and reports (see links to these documents below).
Shaden Kamhawi, a medical entomologist also at NIAID, says the new research "is great, because we really don't know the intricacies of what's going on [in leishmania] transmission.
NIAID could have used this funding process to create a clinical trial infrastructure built for such research.
Although investigators have hypothesized that a two-stage TB skin test might be more reliable than a single-stage test in HIV-infected individuals, a recently completed NIAID study found this not to be the case.